OLATUNDE FATINIKUN: Open Payments
NPI 1942383450 · SEFFNER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 35 payments from 13 companies in 2025. Trend: 2023 $614 · 2024 $773 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $110 |
| E.R. Squibb & Sons, L.L.C. | 5 | $103 |
| Janssen Pharmaceuticals, Inc | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Corium, LLC | 4 | $60 |
| Collegium Pharmaceutical, Inc. | 3 | $60 |
| Lundbeck LLC | 2 | $57 |
| Alkermes, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: REXULTI, VRAYLAR, COBENFY, SPRAVATO, Azstarys, Jornay PM, ARISTADA, CAPLYTA.
Industry payments across FL — which companies pay providers there.
